ESRX has been the topic of a number of other research reports. Robert W. Baird upgraded Express Scripts from a neutral rating to an outperform rating and lifted their target price for the stock from $72.00 to $81.00 in a research report on Friday, December 15th. Zacks Investment Research upgraded Express Scripts from a hold rating to a buy rating and set a $82.00 target price on the stock in a research report on Wednesday, February 14th. Maxim Group reiterated a buy rating and set a $87.00 target price on shares of Express Scripts in a research report on Monday, February 26th. Barclays initiated coverage on Express Scripts in a research report on Thursday. They set an equal weight rating and a $84.00 target price on the stock. Finally, Jefferies Group set a $80.00 target price on Express Scripts and gave the stock a buy rating in a research report on Friday, December 15th. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and eight have assigned a buy rating to the company. The stock has an average rating of Hold and a consensus target price of $81.97.
Shares of Express Scripts (NASDAQ:ESRX) traded up $1.03 during midday trading on Friday, reaching $80.75. The company’s stock had a trading volume of 9,338,071 shares, compared to its average volume of 5,760,000. The stock has a market cap of $44,990.00, a P/E ratio of 10.43, a price-to-earnings-growth ratio of 0.98 and a beta of 0.94. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.67 and a quick ratio of 0.55. Express Scripts has a 12 month low of $55.80 and a 12 month high of $85.07.
Express Scripts announced that its Board of Directors has authorized a share buyback plan on Monday, December 18th that allows the company to repurchase 45,000,000 outstanding shares. This repurchase authorization allows the company to reacquire shares of its stock through open market purchases. Shares repurchase plans are often a sign that the company’s management believes its shares are undervalued.
In other Express Scripts news, VP Glen D. Stettin sold 3,448 shares of Express Scripts stock in a transaction that occurred on Tuesday, January 2nd. The stock was sold at an average price of $76.00, for a total value of $262,048.00. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, VP Glen D. Stettin sold 3,449 shares of Express Scripts stock in a transaction that occurred on Thursday, January 11th. The shares were sold at an average price of $81.00, for a total value of $279,369.00. Following the completion of the sale, the vice president now directly owns 33,715 shares in the company, valued at approximately $2,730,915. The disclosure for this sale can be found here. Insiders sold a total of 21,896 shares of company stock worth $1,617,903 in the last ninety days. 0.68% of the stock is owned by corporate insiders.
Several large investors have recently made changes to their positions in the company. Bank of New York Mellon Corp boosted its stake in shares of Express Scripts by 8.7% during the 4th quarter. Bank of New York Mellon Corp now owns 8,287,905 shares of the company’s stock worth $618,609,000 after acquiring an additional 666,754 shares in the last quarter. Nordea Investment Management AB boosted its stake in shares of Express Scripts by 2.6% during the 3rd quarter. Nordea Investment Management AB now owns 7,304,973 shares of the company’s stock worth $462,551,000 after acquiring an additional 188,528 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Express Scripts by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 6,608,383 shares of the company’s stock worth $492,297,000 after acquiring an additional 32,548 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Express Scripts by 1.3% during the 3rd quarter. Dimensional Fund Advisors LP now owns 6,545,076 shares of the company’s stock worth $414,419,000 after acquiring an additional 86,800 shares in the last quarter. Finally, Ameriprise Financial Inc. boosted its stake in shares of Express Scripts by 23.5% during the 3rd quarter. Ameriprise Financial Inc. now owns 5,233,327 shares of the company’s stock worth $331,374,000 after acquiring an additional 996,816 shares in the last quarter. 87.70% of the stock is currently owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION WARNING: This article was originally posted by Ticker Report and is owned by of Ticker Report. If you are viewing this article on another publication, it was copied illegally and republished in violation of United States and international copyright legislation. The original version of this article can be read at https://www.tickerreport.com/banking-finance/3253614/express-scripts-esrx-lifted-to-market-perform-at-wells-fargo-co.html.
About Express Scripts
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.